Endoscopic Botulinum Toxin Injection for Refractory Enuresis Based on Urodynamic Assessment
Open Access
- 30 September 2021
- journal article
- research article
- Published by Korean Continence Society in International Neurourology Journal
- Vol. 25 (3), 236-243
- https://doi.org/10.5213/inj.2040326.163
Abstract
Purpose: This study aimed to determine the urodynamic characteristics of refractory enuresis and explored whether those characteristics can be managed through differential endoscopic injections with botulinum toxin. Methods: In total, 27 patients with nonmonosymptomatic enuresis who showed no response after conservative treatment for more than 12 months were included. The patients then underwent a videourodynamic study and received a differential endoscopic injection of botulinum toxin on the same day. Reduced capacity, detrusor overactivity, and bladder neck widening were the 3 major abnormal findings assessed during the filling phase, while sphincter hyperactivity was the only abnormality assessed during the emptying phase. An intravesical or intrasphincteric injection of botulinum toxin was attempted according to the videourodynamic study findings. Follow-up was conducted at 1, 3, 6, and 12 months after treatment. Results: The median age was 10 years (range, 7-31 years). Although 19 and 8 patients had a preoperative diagnosis of overactive bladder or dysfunctional voiding, respectively, the urodynamic diagnosis was different in more than half of the patients. Those showing detrusor overactivity benefited from intravesical botulinum toxin injection, whereas those with only sphincter hyperactivity benefited from both intravesical and intrasphincteric injections. Treatment resistance to botulinum toxin seemed to be attributable to bladder neck widening. Time had no apparent effect on efficacy, which persisted 6 months after the injection. More than 80% of the patients maintained the benefits of the injection after 1 year. Conclusions: Videourodynamic studies were useful for identifying the reasons underlying refractory nonmonosymptomatic enuresis and helpful for determining the appropriate site of botulinum toxin injection.Keywords
This publication has 26 references indexed in Scilit:
- Refractory enuresis in children and adolescents: How can urodynamics affect management and what is the optimum test?Journal of Pediatric Urology, 2013
- Evaluation and treatment of nonmonosymptomatic nocturnal enuresis: A standardization document from the International Children's Continence SocietyJournal of Pediatric Urology, 2013
- Practical consensus guidelines for the management of enuresisEuropean Journal of Pediatrics, 2012
- Botulinum A Toxin Urethral Sphincter Injection in Children With Nonneurogenic Neurogenic BladderJournal of Urology, 2006
- High Yield of Urodynamics Performed for Refractory Nonneurogenic Dysfunctional Voiding in the Pediatric PopulationJournal of Urology, 2006
- The Effect of Botulinum-A Toxin in Incontinent Children With Therapy Resistant Overactive DetrusorJournal of Urology, 2006
- Differences in characteristics of nocturnal enuresis between children and adolescents: a critical appraisal from a large epidemiological studyBJU International, 2006
- The role of video-urodynamic studies in managing non-neurogenic voiding dysfunction in childrenBJU International, 2004
- THE USE OF RADIOGRAPHY, URODYNAMIC STUDIES AND CYSTOSCOPY IN THE EVALUATION OF VOIDING DYSFUNCTIONJournal of Urology, 2001
- BLADDER DYSFUNCTION IN CHILDREN WITH REFRACTORY MONOSYMPTOMATIC PRIMARY NOCTURNAL ENURESISJournal of Urology, 1999